Literature DB >> 11035915

Arrest of S-phase progression is impaired in Fanconi anemia cells.

M Sala-Trepat1, D Rouillard, M Escarceller, A Laquerbe, E Moustacchi, D Papadopoulo.   

Abstract

Fanconi anemia (FA) is an inherited cancer-susceptibility disorder, characterized by genomic instability, hypersensitivity to DNA cross-linking agents, and a prolonged G2 phase of the cell cycle. We observed a marked dose-dependent accumulation of FA cells in the G2 compartment after treatment with 4,5',8-trimethylpsoralen (Me(3)Pso) in combination with 365 nm irradiation. Using bivariate DNA distribution methodology, we determined the proportion of replicating and arresting S-phase cells and observed that, whereas normal cells arrested DNA replication in the presence of Me(3)Pso cross-links and monoadducts, FA lymphoblasts failed to arrest DNA synthesis. Taken together, the above data suggest that, in response to damage induced by DNA cross-linking agents, the S-phase checkpoint is inefficient in FA cells. This would lead to accumulation of secondary lesions, such as single- and double-strand breaks and gaps. The prolonged time in G2 phase seen in FA cells therefore exists in order to allow the cells to remove lesions which accumulated during the preceding abnormal S phase. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035915     DOI: 10.1006/excr.2000.4994

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

Review 2.  Advances in the understanding of the Fanconi anemia tumor suppressor pathway.

Authors:  Anna Pickering; Jun Zhang; Jayabal Panneerselvam; Peiwen Fei
Journal:  Cancer Biol Ther       Date:  2013-09-09       Impact factor: 4.742

3.  The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response.

Authors:  Min Huang; Jung Min Kim; Bunsyo Shiotani; Kailin Yang; Lee Zou; Alan D D'Andrea
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

4.  Cho Endonuclease Functions during DNA Interstrand Cross-Link Repair in Escherichia coli.

Authors:  Anthonige Vidya Perera; James Brian Mendenhall; Charmain Tan Courcelle; Justin Courcelle
Journal:  J Bacteriol       Date:  2016-10-21       Impact factor: 3.490

5.  Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination.

Authors:  Aleksandra M Gorniewska; Katarzyna Kluzek; Lidia Gackowska; Izabela Kubiszewska; Malgorzata Z Zdzienicka; Aneta Bialkowska
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

6.  BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.

Authors:  Céline J Rocca; Daniele G Soares; Hana Bouzid; João A P Henriques; Annette K Larsen; Alexandre E Escargueil
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs.

Authors:  Guang-Hui Liu; Keiichiro Suzuki; Mo Li; Jing Qu; Nuria Montserrat; Carolina Tarantino; Ying Gu; Fei Yi; Xiuling Xu; Weiqi Zhang; Sergio Ruiz; Nongluk Plongthongkum; Kun Zhang; Shigeo Masuda; Emmanuel Nivet; Yuji Tsunekawa; Rupa Devi Soligalla; April Goebl; Emi Aizawa; Na Young Kim; Jessica Kim; Ilir Dubova; Ying Li; Ruotong Ren; Chris Benner; Antonio Del Sol; Juan Bueren; Juan Pablo Trujillo; Jordi Surralles; Enrico Cappelli; Carlo Dufour; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Nat Commun       Date:  2014-07-07       Impact factor: 14.919

Review 8.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

9.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

10.  The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways.

Authors:  Alexandra Sobeck; Stacie Stone; Igor Landais; Bendert de Graaf; Maureen E Hoatlin
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.